MSBIO Inc

MSBIO Inc

KKRX:0013Y0
9,690.00
KRW
-3,630.00
(-27.25%)
No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

Sector
Health technology
Industry
Medical specialties
Address
Seongnam-si South Korea
IPO Date
Oct 22, 2026
Business
MS Bio, Inc. engages in the research and development of treatments for diseases using human tissue and biomaterials. Its products and services include the tissue bank and medical devices. The company was founded on October 27, 2015 and is headquartered in Seongnam-si, South Korea.